JP2023527791A5 - - Google Patents
Info
- Publication number
- JP2023527791A5 JP2023527791A5 JP2022572323A JP2022572323A JP2023527791A5 JP 2023527791 A5 JP2023527791 A5 JP 2023527791A5 JP 2022572323 A JP2022572323 A JP 2022572323A JP 2022572323 A JP2022572323 A JP 2022572323A JP 2023527791 A5 JP2023527791 A5 JP 2023527791A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- insert
- nucleic acid
- expression vector
- dosage form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063030214P | 2020-05-26 | 2020-05-26 | |
| US63/030,214 | 2020-05-26 | ||
| PCT/US2021/033848 WO2021242675A1 (en) | 2020-05-26 | 2021-05-24 | Methods for the treatment of viral respiratory infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527791A JP2023527791A (ja) | 2023-06-30 |
| JP2023527791A5 true JP2023527791A5 (https=) | 2024-05-22 |
Family
ID=76859702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572323A Pending JP2023527791A (ja) | 2020-05-26 | 2021-05-24 | ウイルス性呼吸器感染症を治療するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230144927A1 (https=) |
| EP (1) | EP4158025A1 (https=) |
| JP (1) | JP2023527791A (https=) |
| CN (1) | CN116710118A (https=) |
| WO (1) | WO2021242675A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022055817A1 (en) * | 2020-09-09 | 2022-03-17 | Gradalis, Inc. | Composition formulated into inhalable dosage forms for the treatment of lung|tumors |
| EP4440704A2 (en) * | 2021-11-30 | 2024-10-09 | Gradalis, Inc. | Methods for treatment response to cancers |
| WO2023137404A1 (en) * | 2022-01-12 | 2023-07-20 | University Of Virginia Patent Foundation | Spike furin cleavage is a sars-cov-2 targeting strategy to break the chain of infection cycle |
| EP4507720A1 (en) * | 2022-04-14 | 2025-02-19 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Alpha-1-antitrypsin for treating paramyxoviridae or orthomyxoviridae infections |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009214443B2 (en) | 2008-02-13 | 2013-10-10 | Board Of Regents, The University Of Texas System | Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
| US9157084B2 (en) * | 2009-12-23 | 2015-10-13 | Gradalis, Inc. | Furin-knockdown bi-functional RNA |
| SG181880A1 (en) * | 2009-12-23 | 2012-07-30 | Gradalis Inc | Furin-knockdown and gm-csf-augmented (fang) cancer vaccine |
-
2021
- 2021-05-24 WO PCT/US2021/033848 patent/WO2021242675A1/en not_active Ceased
- 2021-05-24 CN CN202180060820.8A patent/CN116710118A/zh active Pending
- 2021-05-24 EP EP21740276.7A patent/EP4158025A1/en not_active Withdrawn
- 2021-05-24 JP JP2022572323A patent/JP2023527791A/ja active Pending
-
2022
- 2022-10-31 US US17/977,979 patent/US20230144927A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023527791A5 (https=) | ||
| JP2026026092A5 (https=) | ||
| JPH06508039A (ja) | 抗腫瘍治療のためのサイトカインを発現する組換え型欠損アデノウイルス | |
| US20090227511A1 (en) | Methods and compositions for treating lesions of the respiratory epithelium | |
| JP2007509607A5 (https=) | ||
| TW201408309A (zh) | 用於治療ｂ型肝炎及ｄ型肝炎感染之方法 | |
| JP2023536570A5 (https=) | ||
| CN112143731B (zh) | 靶向破坏SARS-CoV-2病毒基因组的gRNA及其应用 | |
| JP2020105169A5 (https=) | ||
| JP2023527791A (ja) | ウイルス性呼吸器感染症を治療するための方法 | |
| CN112439058A (zh) | 基于外泌体为载体的重组新型冠状病毒纳米疫苗方法 | |
| JP2005508158A5 (https=) | ||
| WO2022056897A1 (zh) | 白细胞介素37与干扰素联用在治疗病毒感染中的应用 | |
| US8075877B2 (en) | Broad spectrum immune and antiviral gene modulation by oral interferon | |
| WO2023023597A1 (en) | Virus-like particle | |
| US20220251601A1 (en) | mRNA NANOCAPSULE AND USE IN PREPARATION OF ANTIVIRAL DRUGS | |
| US12274724B2 (en) | Methods for treatment of cancer using chikungunya-VSV chimeric virus | |
| CN119679932A (zh) | 效能延长型新冠病毒自复制核酸疫苗 | |
| TW Clarke et al. | Targeted drug delivery to the virus-infected airway; complications and remedies | |
| JP2013529082A (ja) | 遺伝子組み換えｒｓウイルスを使用した乳がん治療 | |
| JP2023529152A5 (https=) | ||
| Deanasa et al. | The potential of antisense oligonucleotides (ASO) through inhalation based on gold nanoparticle (AuNP) delivery system in inhibiting SARS-CoV-2 replication and transcription | |
| CN118634243B (zh) | Mir2911在制备抗登革病毒denv的药物中的应用 | |
| CN121517529A (zh) | 一种微肽cim53及其编码基因和应用 | |
| CN118662522B (zh) | Mir2911在制备抗黄热病毒yfv的药物中的应用 |